Skip navigation

Evaluate the Impact of Potential Changes for Pharmacies and PBMs

June 13-14, 2019
  • Washington, DC

Daniel Ashworth
Counsel for Ranking Member Doug Collins and
the House Judiciary Committee Minority
U.S. House of Representatives

Brett Baker
Senior Health Policy Advisor
Senate Committee on Finance (invited)

 

Dea Belazi, Pharm.D.,MPH
President & CEO
AscellaHealth LLC

Matthew Chamblee, FSA, MAAA
Principal and Consulting Actuary
Milliman, Inc.

Laura Cranston
Chief Executive Officer
Pharmacy Quality Alliance (PQA)

Sean Dickson, JD, MPH
Director, Health Policy
West Health Policy Center

David Farber
Partner, FDA and Life Sciences
King & Spalding

Kyle Fields
Chief Executive Officer
Appro-RX

Matthew Hayes FSA, MAAA
Consulting Actuary
Milliman, Inc.

Sherry Pound
Principal
BluePeak Advisors

Todd Sega, PharmD
Vice President, Payer Relations
Pharmacy Quality Solutions (PQS)

Kala Shankle, JD
Director, Policy & Regulatory Affairs
National Community Pharmacists Association

Jayson Slotnik
Partner
Health Policy Strategies, Inc.

Chris Smith
Director, Product Strategy Pharmacy
Inmar

Gordon Smith
Director, Pharmacy Revenue Cycle
Vanderbilt University Medical Center

Paul Urick, RPh
Chief Executive Officer
URx

Angus B. Worthing MD
Vice President, Alliance for Transparent & Affordable Prescriptions
Partner, Arthritis & Rheumatism Associates
Chair, Government Affairs Committee, American College of Rheumatology

Daniel Ashworth
Counsel for Ranking Member Doug Collins and
the House Judiciary Committee Minority
U.S. House of Representatives

Brett Baker
Senior Health Policy Advisor
Senate Committee on Finance (invited)

 

Dea Belazi, Pharm.D.,MPH
President & CEO
AscellaHealth LLC

Matthew Chamblee, FSA, MAAA
Principal and Consulting Actuary
Milliman, Inc.

Laura Cranston
Chief Executive Officer
Pharmacy Quality Alliance (PQA)

Sean Dickson, JD, MPH
Director, Health Policy
West Health Policy Center

David Farber
Partner, FDA and Life Sciences
King & Spalding

Kyle Fields
Chief Executive Officer
Appro-RX

Matthew Hayes FSA, MAAA
Consulting Actuary
Milliman, Inc.

Sherry Pound
Principal
BluePeak Advisors

Todd Sega, PharmD
Vice President, Payer Relations
Pharmacy Quality Solutions (PQS)

Kala Shankle, JD
Director, Policy & Regulatory Affairs
National Community Pharmacists Association

Jayson Slotnik
Partner
Health Policy Strategies, Inc.

Chris Smith
Director, Product Strategy Pharmacy
Inmar

Gordon Smith
Director, Pharmacy Revenue Cycle
Vanderbilt University Medical Center

Paul Urick, RPh
Chief Executive Officer
URx

Angus B. Worthing MD
Vice President, Alliance for Transparent & Affordable Prescriptions
Partner, Arthritis & Rheumatism Associates
Chair, Government Affairs Committee, American College of Rheumatology